Home > About Us
MISSION
Onset Therapeutics is dedicated to addressing unmet clinical needs with novel technological solutions that optimize the delivery, performance and patient acceptability of the pharmaceutical product, which in turn will improve patient care.
Onset Therapeutics strives to provide the highest quality products and customer service with the ultimate goal of improving the quality of life for patients in need.
Onset Therapeutics
400 Highland Corporate Drive
Cumberland, RI 02864
Tel: 888-713-8154
www.onsettx.com
ABOUT THE COMPANY
Onset Therapeutics, a wholly owned subsidiary of Collegium Pharmaceutical (www.collegiumpharma.com), is an emerging leader in the development and commercialization of novel, patent protected products for the treatment of skin disorders and wounds. Our commitment to excellence is the cornerstone of our business. We work hard to provide new, optimized, innovative, practical and cost effective pharmaceutical products to the healthcare market in an effort to improve the quality of life for patients. Our scientists pride themselves on thoroughly understanding the specific clinical needs of skin conditions and wound care as well as the limitations of currently available treatments. They then tailor their product development efforts to optimize the treatment of these conditions, resulting in revolutionary products that further advance patient care.
Our experienced clinical support and commercialization teams are dedicated to providing a streamlined approach to your pharmaceutical product needs. The goal is to provide the most cost-effective products for healthcare providers and their patients.
CAPABILITIES
- Intellectual Property Development
- Formulation Development
- GMP Manufacturing
- Clinical Development
- Product Commercialization
MANAGEMENT TEAM
Our seasoned management team has had significant experience in the development, manufacturing and commercialization of numerous pharmaceutical products over the past 30 years.
Onset Therapeutics is currently offering new, innovative products for the following areas:
WOUND CARE
- Optase®
- Paptase®
- Full pipeline of additional wound care products
DERMATOLOGY
- Kerafoam®
- ClarifoamTM EF
- SalkeraTM
- AnestafoamTM
- Full pipeline of additional dermatology products.
DelevoTM Foam Technology is the patented foam formulation used for multiple existing Onset products as well as many of the products in development. DelevoTM Foam Technology combines proven effective, active ingredients with an advanced formulation designed to improve patient compliance, resulting in more successful outcomes.